0

Isodiol International Inc. Aligns with Salesbird for U.S. And Global Hemp CBD Product Distribution 

Isodiol increases its salesforce with established U.S. and international distribution for traditional and online consumer retail market expansion.  SEPTEMBER 17, 2020 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) is pleased to announce the execution of a non- exclusive distribution agreement with SalesBird, LLC, a well-established…

Read More

Isodiol International Inc. Provides Corporate Update

SEPTEMBER 9, 2020 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) is completing the final stage of restructuring from a traditional business model to an agile, global online sales, research and development company. From executive staff to remote support, Isodiol has navigated extreme change amid COVID-19…

Read More

Isodiol International Inc. Announces Delay in Filing Annual Financial Statements

JULY 30, 2020 – Vancouver, BC – Isodiol International Inc.(CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) announces that due to circumstances created by the COVID-19 global pandemic, the Company will not be filing its audited financial statements, related management discussion and analysis and certifications of the financial statements for the fiscal year…

Read More

Isodiol International Inc. Announces Sweeping Executive Management Changes

July 27, 2020 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), officially launches the search for a new CFO, following the departure of Eli Dusenberry, legacy executive. Dear Shareholders, We like to announce our search for a new permanent CFO, one who is in alignment with…

Read More
President

Isodiol International Inc. adds Andrew S. Alvis to its Board of Directors and appointed Chairman of Audit Committee

May 13, 2020 – Vancouver, BC –  Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F)(the “Company” or “Isodiol”), today announces the addition of its current President, Andrew Stanton Alvis, to its growing Board of Directors and appointed Chairman of the Audit Committee. Mr. Alvis brings to Isodiol and its board of directors his extensive experience in…

Read More

Isodiol International Inc. Announces Shareholder Update

April 3, 2020 – Vancouver, BC – Isodiol International Inc.(CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), is pleased to announce a shareholder update. Dear Shareholders, The COVID-19 virus represents a new challenge for us all, and I want to formally update you on the situation as it pertains to Isodiol. We are…

Read More

Isodiol International Inc. Announces Debt Restructuring

April 1, 2020 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), is pleased to announce that it has reached an agreement with the holders of its outstanding $6,000,000 CAD aggregate principal amount of 8.00% secured convertible debentures (the “Holders”) that mature on November 29, 2020 (the…

Read More

Isodiol International Inc. Reports Third Quarter 2020 Financial Results

March 3,  2020 –  Vancouver,  BC  – Isodiol  International  Inc. (CSE: ISOL)  (OTCQB:  ISOLF)  (FSE: LB6B.F) (the“Company” or “Isodiol”), announces that it has filed itsconsolidated financial statements and MD&A for the nine months ended December 31, 2019. Highlights of the third quarter of fiscal 2020 include: • Revenues of $1.3M and gross margins of $489k,…

Read More

Isodiol International Inc. Announces The Launch of It’s Pawceuticals Brand

Oct 3, 2019 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), announces that Pawceuticals, the CBD-based product line that naturally helps to restore a pet’s health and overall wellness, is now available to purchase across the United States. The Pawceuticals functional CBD pet products are designed…

Read More

Isodiol International Inc. Announces Appointment of Andrew Alvis As President

Oct 1, 2019 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), announces the appointment of Andrew Alvis to serve as the Company’s President. Mr. Alvis has diverse experience in all aspects of leadership, operational efficiency and revenue growth. He possesses a background that spans across multiple…

Read More
ISODIOL INTERNATIONAL INC. REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

Isodiol International Inc. Reports First Quarter 2020 Financial Results

Aug 30, 2019 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F)(the “Company” or “Isodiol”), announces that it has filed its audited consolidated financial statements and MD&A for the year ended June 30, 2019. Highlights of Fiscal Year 2019 include: The Company reports first quarter revenues of $4.2M, a significant reduction in operating expenses and…

Read More

Isodiol International Inc. Reports Fiscal Year 2019 Audited Financial Results

Aug 16, 2019 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F)(the “Company” or “Isodiol”), announces that it has filed its audited consolidated financial statements and MD&A for the year ended March 31, 2019. Highlights of Fiscal Year 2019 include: Total revenues of $22,248,171, an increase of 16.26% over the prior year, and which…

Read More
Strategic financing

Isodiol International Inc Provides an Update on the Delay in Filing Its Audited Financial Statements

Aug 12, 2019 – Vancouver, BC –  Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F)(the “Company” or “Isodiol”), provides an update on the delay on the filing of its audited annual financial statements, related management’s discussion and analysis and supporting officer certificates for the financial year ended March 31, 2019 (the “Filings”). The Company obtained a management cease…

Read More

Isodiol International Inc. – Delay In Filing Audited Financial Statements – Obtains Management Cease Trade Order from BCSC

July 30, 2019 – Vancouver, BC –  Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F)(the “Company” or “Isodiol”), today announces a delay in the filing of its audited annual financial statements, related management’s discussion and analysis and supporting officer certificates for the financial year ended March 31, 2019 (the “Filings”). The Filings are required to be made…

Read More

Subscribe to our newsletter and get 20% off your entire order!